Country: Malta
Language: English
Source: Medicines Authority
RANITIDINE
Glaxo Wellcome UK Limited 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
A02BA02
RANITIDINE 300 mg
TABLET
RANITIDINE 300 mg
POM
DRUGS FOR ACID RELATED DISORDERS
Withdrawn
2006-09-18
PACKAGE LEAFLET: INFORMATION FOR THE USER ZANTAC ® TABLETS 150 MG AND 300 MG RANITIDINE HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 What Zantac is and what it is used for 2 What you need to know before you take Zantac 3 How to take Zantac Tablets 4 Possible side effects 5 How to store Zantac 6 Contents of the pack and other information 1 WHAT ZANTAC IS AND WHAT IT IS USED FOR Zantac contains a medicine called ranitidine. This belongs to a group of medicines called H 2 -receptor antagonists. It lowers the amount of acid in your stomach. For adults (including the elderly) Zantac is used to: heal and stop ulcers in the stomach, or the part of the gut it empties into (the duodenum) help clear up infection in your stomach, when taken with antibiotic medicines (medicines taken to treat germs) stop stomach ulcers when they are a side effect of some medicines stop ulcers from bleeding improve problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as ‘indigestion’, ‘dyspepsia’ or ‘heartburn Read the complete document
Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. TRADE NAME OF THE MEDICINAL PRODUCT Zantac Tablets 300 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains ranitidine 300 mg (as the hydrochloride). 3. PHARMACEUTICAL FORM Tablet. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Adults Zantac Tablets are indicated for: treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. treatment of duodenal ulcers associated with _Helicobacter pylori _infection. treatment of post-operative ulcer Zollinger-Ellison syndrome oesophageal reflux disease chronic episodic dyspepsia, characterised by pain (epigastric or retrosternal) which is related to meals or disturbs sleep but is not associated with the preceding conditions may benefit from ranitidine treatment. Zantac Tablets are indicated for the following conditions where reduction of gastric secretion and acid output is desirable: prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's syndrome), particularly obstetric patients during labour. For appropriate cases Zantac Injection is also available (see separate SPC). Page 2 of 11 Children (3 to 18 years) Short term treatment of peptic ulcer Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gas Read the complete document